INMUNE BIO INC. - COMMON STOCK
10.14
23-四月-24 15:59:54
15 分钟延时
股票
-0.48
-4.56%
今日范围
9.62 - 10.55
ISIN
N/A
来源
NASDAQ
-
23 4月 2024 08:00:00 条件 Nasdaq GlobeNewswire
-
08 4月 2024 08:00:01 条件 Nasdaq GlobeNewswire
-
INmune Bio Inc. Announces Year End 2023 Results and Provides a Q4 Business Update
28 3月 2024 16:01:53 条件 Nasdaq GlobeNewswire
-
26 3月 2024 16:01:00 条件 Nasdaq GlobeNewswire
-
13 3月 2024 08:00:00 条件 Nasdaq GlobeNewswire
-
INmune Bio Reports Significant EEG Improvement in Alzheimer’s Patients Treated with XPro™
05 3月 2024 08:00:00 条件 Nasdaq GlobeNewswire
-
INmune Bio to Participate in the Oppenheimer 34th Annual Healthcare Life Sciences Conference
12 2月 2024 09:00:00 条件 Nasdaq GlobeNewswire
-
INmune Bio to Participate in Baird’s Biotech Discovery Series Webcast on February 13, 2024
06 2月 2024 09:00:00 条件 Nasdaq GlobeNewswire
-
INmune Bio Announces FDA Removal of Clinical Hold for Alzheimer’s Disease Program
30 1月 2024 08:00:00 条件 Nasdaq GlobeNewswire
-
02 1月 2024 08:00:00 条件 Nasdaq GlobeNewswire
-
18 12月 2023 16:01:00 条件 Nasdaq GlobeNewswire
-
27 11月 2023 08:00:00 条件 Nasdaq GlobeNewswire
-
INmune Bio Inc. Announces Expansion of Phase II Clinical Trial for Alzheimer’s Disease in Europe
15 11月 2023 09:00:00 条件 Nasdaq GlobeNewswire
-
INmune Bio Inc. Announces Third Quarter 2023 Results and Provides Business Update
01 11月 2023 16:10:41 条件 Nasdaq GlobeNewswire
-
31 10月 2023 08:00:00 条件 Nasdaq GlobeNewswire
-
30 10月 2023 09:07:00 条件 Nasdaq GlobeNewswire
-
16 10月 2023 09:00:00 条件 Nasdaq GlobeNewswire
- <<
- <
- 1
- >